BSX vs UPXI · P/E 20, rev $10.65B vs P/E 1.8, rev $15.8M
Boston Scientific Corp (BSX) versus Upexi Inc. (UPXI) — a side-by-side from cached financials, not a winner call.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
Upexi Inc. (UPXI) is a internet content & information company listed on NASDAQ.
Latest reported BSX revenue for 2026-06-30 was $10.65B. Net income was $2.24B. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
Latest reported UPXI revenue for 2025-06-30 was $15.8M. Net income was -$13.7M. UPXI currently screens at market cap $65.3M and trailing P/E 1.8.
BSX currently screens at market cap $71.81B and trailing P/E 20.2. UPXI currently screens at market cap $65.3M and trailing P/E 1.8.
Not investment advice. Open the BSX and UPXI stock pages for the full models.
Not investment advice.